ArticleJournal of experimental & clinical cancer research : CR2020

Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.